1. Home
  2. SOPH vs PROF Comparison

SOPH vs PROF Comparison

Compare SOPH & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$4.51

Market Cap

330.4M

Sector

Health Care

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.56

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
PROF
Founded
2011
N/A
Country
Switzerland
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.4M
230.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPH
PROF
Price
$4.51
$7.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$11.00
AVG Volume (30 Days)
76.0K
150.0K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$73,297,000.00
$14,297,000.00
Revenue This Year
$18.32
$64.23
Revenue Next Year
$15.61
$113.06
P/E Ratio
N/A
N/A
Revenue Growth
13.66
67.94
52 Week Low
$2.58
$3.76
52 Week High
$5.30
$7.99

Technical Indicators

Market Signals
Indicator
SOPH
PROF
Relative Strength Index (RSI) 47.87 60.31
Support Level $4.60 $7.02
Resistance Level $4.84 $7.75
Average True Range (ATR) 0.23 0.40
MACD -0.03 -0.01
Stochastic Oscillator 17.51 69.66

Price Performance

Historical Comparison
SOPH
PROF

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: